The WHO rules stimulate the adoption of those technologies, presented they can be validated to demonstrate equivalent or remarkable efficiency compared to traditional approaches. Manufacturers trying to put into practice these solutions must provide strong validation details to reveal their equivalence to pharmacopoeial solutions. The ava